Related references
Note: Only part of the references are listed.Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries
Deepak M. W. Balak et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Joint AADeNPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
Craig A. Elmets et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis
Victoria Amat-Samaranch et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data
Matteo Megna et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
The current landscape of psoriasis genetics in 2020
Kotaro Ogawa et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Two cases of refractory nail psoriasis successfully treated with calcipotriol plus betamethasone dipropionate gel
Hiroyuki Takama et al.
JOURNAL OF DERMATOLOGY (2020)
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra-patient, left-to-right prospective study
S. Gregoriou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Plaque-Type Psoriasis Treated with Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam: A Prospective Study on Clinical and Dermoscopic Predictor Factors in Response Achievement and Retention
Enzo Errichetti et al.
DERMATOLOGY AND THERAPY (2020)
Spotlight on Topical Long-Term Management of Plaque Psoriasis
Jose Manuel Carrascosa et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis
Linda Stein Gold et al.
ADVANCES IN THERAPY (2020)
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication
Leon Kircik et al.
JOURNAL OF DRUGS IN DERMATOLOGY (2020)
Treating Scalp Psoriasis With Calcipotriene/Betamethasone Dipropionate Cutaneous Foam: Review of Phase 2 Data
Bibi Petersen et al.
JOURNAL OF DRUGS IN DERMATOLOGY (2020)
Twice-weekly topical calcipotriene / betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
Mark Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis
Jerry Bagel et al.
DERMATOLOGY AND THERAPY (2020)
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial
Lunfei Liu et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2020)
Apremilast With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis
Jerry Bagel et al.
JOURNAL OF DRUGS IN DERMATOLOGY (2020)
Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1
Adam Reich et al.
PRZEGLAD DERMATOLOGICZNY (2020)
Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments
Elise C. Kleyn et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Imaging techniques in the diagnosis and monitoring of psoriasis
Ioana-Alina Grajdeanu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model
Kyosuke Satake et al.
SCIENTIFIC REPORTS (2019)
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison
A. P. Bewley et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden
Albert Duvetorp et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam
L. Puig et al.
ACTAS DERMO-SIFILIOGRAFICAS (2019)
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study
Christopher Em Griffiths et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2018)
Comparing the Efficacy of Triamcinolone Acetonide Iontophoresis versus Topical Calcipotriol/Betamethasone Dipropionate in Treating Nail Psoriasis: A Bilateral Controlled Clinical Trial
Nasrin Saki et al.
DERMATOLOGY RESEARCH AND PRACTICE (2018)
Treatment of Genital Psoriasis: A Systematic Review
Kristen M. Beck et al.
DERMATOLOGY AND THERAPY (2018)
Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review
J. G. Schlager et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile
Carle Paul et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study
C. Paul et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study
C-H. Hong et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review
Nupur U. Patel et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)
Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus
Andrea Chiricozzi et al.
DERMATOLOGIC THERAPY (2017)
Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population
Li Ma et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice
Adria Gual et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris - A randomized phase II study
John Koo et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments
C. Queille-Roussel et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients
Marianne Lind et al.
DERMATOLOGY AND THERAPY (2016)
Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study
Jung-Min Park et al.
ANNALS OF DERMATOLOGY (2015)
Cytokines in psoriasis
Jaymie Baliwag et al.
CYTOKINE (2015)
Immunology of Psoriasis
Michelle A. Lowes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients
Rosita Saraceno et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Spotlight on Calcipotriene/Betamethasone Dipropionate in Psoriasis Vulgaris of the Trunk, Limbs, and Scalp
Paul L. McCormack
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: A systematic review of direct and indirect evidence
Julia M. Bottomley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Calcipotriol/Betamethasone Dipropionate A Review of its Use in the Treatment of Psoriasis Vulgaris of the Trunk, Limbs and Scalp
Paul L. McCormack
DRUGS (2011)
Treatment of Nail Psoriasis with a Two-Compound Formulation of Calcipotriol plus Betamethasone Dipropionate Ointment
D. Rigopoulos et al.
DERMATOLOGY (2009)
Dovobet (R) ointment under occlusion overnight for troublesome scalp psoriasis
AMR Downs
ACTA DERMATO-VENEREOLOGICA (2006)
Bioavailability of betamethasone dipropionate when combined with calcipotriol
J Traulsen
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
Share Paper
